Search Page

1

Cite

Share

Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis.

Lucaciu LA, Constantine-Cooke N, Plevris N, Siakavellas S, Derikx LAAP, Jones GR, Lees CW. Lucaciu LA, et al. Among authors: plevris n. Therap Adv Gastroenterol. 2021 Dec 23;14:17562848211064004. doi: 10.1177/17562848211064004. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34987608 Free PMC article.

Cite

Share

2

Cite

Share

Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.

Jenkinson PW, Plevris N, Lyons M, Grant R, Fulforth J, Kirkwood K, Arnott ID, Wilson D, Watson AJM, Jones GR, Lees CW. Jenkinson PW, et al. Among authors: plevris n. Colorectal Dis. 2021 May;23(5):1175-1183. doi: 10.1111/codi.15491. Epub 2021 Feb 17. Colorectal Dis. 2021. PMID: 33350054

Cite

Share

3

Cite

Share

IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology.

Jones GR, Lyons M, Plevris N, Jenkinson PW, Bisset C, Burgess C, Din S, Fulforth J, Henderson P, Ho GT, Kirkwood K, Noble C, Shand AG, Wilson DC, Arnott ID, Lees CW. Jones GR, et al. Among authors: plevris n. Gut. 2019 Nov;68(11):1953-1960. doi: 10.1136/gutjnl-2019-318936. Epub 2019 Jul 11. Gut. 2019. PMID: 31300515 Free PMC article.

Cite

Share

4

Cite

Share

Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.

Plevris N, Fulforth J, Siakavellas S, Robertson A, Hall R, Tyler A, Jenkinson PW, Campbell I, Chuah CS, Kane C, Veryan J, Lam WL, Saunders J, Kelly C, Gaya D, Jafferbhoy H, Macdonald JC, Seenan JP, Mowat C, Naismith G, Potts LF, Sutherland DI, Watts D, Arnott I, Bain G, Jones G, Lees CW. Plevris N, et al. J Gastroenterol Hepatol. 2021 Aug;36(8):2067-2075. doi: 10.1111/jgh.15390. Epub 2021 Mar 5. J Gastroenterol Hepatol. 2021. PMID: 33381875

Cite

Share

5

Cite

Share

The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.

Grant RK, Jones GR, Plevris N, Lynch RW, Jenkinson PW, Lees CW, Manship TA, Jagger FAM, Brindle WM, Shivakumar M, Satsangi J, Arnott IDR. Grant RK, et al. Among authors: plevris n. Inflamm Bowel Dis. 2021 Mar 15;27(4):451-457. doi: 10.1093/ibd/izaa088. Inflamm Bowel Dis. 2021. PMID: 32572468

Cite

Share

6

Cite

Share

Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.

Plevris N, Lees CW. Plevris N, et al. Gastroenterology. 2022 Apr;162(5):1456-1475.e1. doi: 10.1053/j.gastro.2022.01.024. Epub 2022 Jan 29. Gastroenterology. 2022. PMID: 35101422 Free article. Review.

Cite

Share

7

Cite

Share

Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.

Plevris N, Fulforth J, Lyons M, Siakavellas SI, Jenkinson PW, Chuah CS, Lucaciu L, Pattenden RJ, Arnott ID, Jones GR, Lees CW. Plevris N, et al. Clin Gastroenterol Hepatol. 2021 Sep;19(9):1835-1844.e6. doi: 10.1016/j.cgh.2020.08.022. Epub 2020 Aug 13. Clin Gastroenterol Hepatol. 2021. PMID: 32798706

Cite

Share

8

Cite

Share

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts.

Derikx LAAP, Dolby HW, Plevris N, Lucaciu L, Rees CS, Lyons M, Siakavellas SI, Constantine-Cooke N, Jenkinson P, Su S, O'Hare C, Kirckpatrick L, Merchant LM, Noble C, Arnott ID, Jones GR, Lees CW. Derikx LAAP, et al. Among authors: plevris n. J Crohns Colitis. 2021 Dec 18;15(12):2011-2021. doi: 10.1093/ecco-jcc/jjab100. J Crohns Colitis. 2021. PMID: 34089587 Free PMC article.

Cite

Share

9

Cite

Share

Radical Surgical Procedures in Advanced Ovarian Cancer and Differences Between Primary and Interval Debulking Surgery.

Mitsopoulos V, Innamaa A, Lippiatt J, Plevris N, Biliatis I. Mitsopoulos V, et al. Among authors: plevris n. Anticancer Res. 2020 Oct;40(10):5869-5875. doi: 10.21873/anticanres.14606. Anticancer Res. 2020. PMID: 32988917

Cite

Share

10

Cite

Share

Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.

Kennedy NA, Jones GR, Plevris N, Patenden R, Arnott ID, Lees CW. Kennedy NA, et al. Among authors: plevris n. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2269-2276.e4. doi: 10.1016/j.cgh.2019.02.017. Epub 2019 Feb 14. Clin Gastroenterol Hepatol. 2019. PMID: 30772585 Free PMC article.

Cite

Share